XML 253 R196.htm IDEA: XBRL DOCUMENT v3.25.0.1
Provisions for discounts, rebates and sales returns - Summary of Movement in Provisions for Discounts, Rebates and Sales Returns (Details) - EUR (€)
€ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disclosure of other provisions [line items]      
Provisions for discounts, rebates and sales returns, beginning balance € 7,762 [1] € 6,490 [1] € 5,899
Changes in scope of consolidation [2]     (3)
Provision related to current period sales 23,290 24,296 22,141
Net change in provision related to prior period sales (282) (155) (315)
Payments made (23,482) (22,653) (21,699)
Currency translation differences 303 (213) 464
Increase Decrease Through Reclassification of Business, Other Provisions [3] (264)    
Provisions for discounts, rebates and sales returns, ending balance [1] 7,328 7,762 6,490
Government and State Programs      
Disclosure of other provisions [line items]      
Provisions for discounts, rebates and sales returns, beginning balance [2] 2,962 [1] 2,603 [1] 2,596
Changes in scope of consolidation [2]     2
Provision related to current period sales [2] 5,401 7,758 6,744
Net change in provision related to prior period sales [2] (177) (74) (120)
Payments made [2] (5,599) (7,251) (6,824)
Currency translation differences [2] 143 (76) 207
Increase Decrease Through Reclassification of Business, Other Provisions [2],[3] (24)    
Provisions for discounts, rebates and sales returns, ending balance [1],[2] 2,706 2,962 2,603
Managed care and GPO Programs      
Disclosure of other provisions [line items]      
Provisions for discounts, rebates and sales returns, beginning balance [4] 1,119 [1] 1,021 [1] 931
Changes in scope of consolidation [2]     0
Provision related to current period sales [4] 3,961 3,590 3,246
Net change in provision related to prior period sales [4] (5) (12) (47)
Payments made [4] (3,882) (3,446) (3,208)
Currency translation differences [4] 77 (34) 99
Increase Decrease Through Reclassification of Business, Other Provisions [3],[4] 0    
Provisions for discounts, rebates and sales returns, ending balance [1],[4] 1,270 1,119 1,021
Chargeback incentives      
Disclosure of other provisions [line items]      
Provisions for discounts, rebates and sales returns, beginning balance 637 [1] 362 [1] 303
Changes in scope of consolidation [2]     (1)
Provision related to current period sales 3,093 3,861 4,147
Net change in provision related to prior period sales (26) (9) (21)
Payments made (3,336) (3,564) (4,093)
Currency translation differences 36 (12) 26
Increase Decrease Through Reclassification of Business, Other Provisions [3] (6)    
Provisions for discounts, rebates and sales returns, ending balance [1] 398 637 362
Rebates and discounts      
Disclosure of other provisions [line items]      
Provisions for discounts, rebates and sales returns, beginning balance 2,269 [1] 1,805 [1] 1,425
Changes in scope of consolidation [2]     (6)
Provision related to current period sales 9,758 8,177 7,244
Net change in provision related to prior period sales (34) (58) (138)
Payments made (9,678) (7,603) (6,809)
Currency translation differences 8 (46) 83
Increase Decrease Through Reclassification of Business, Other Provisions [3] (201)    
Provisions for discounts, rebates and sales returns, ending balance [1] 2,122 2,269 1,805
Sales returns      
Disclosure of other provisions [line items]      
Provisions for discounts, rebates and sales returns, beginning balance 715 [1] 629 [1] 610
Changes in scope of consolidation [2]     (2)
Provision related to current period sales 595 654 578
Net change in provision related to prior period sales (54) (25) (8)
Payments made (491) (511) (599)
Currency translation differences 41 (30) 48
Increase Decrease Through Reclassification of Business, Other Provisions [3] (30)    
Provisions for discounts, rebates and sales returns, ending balance [1] 776 715 629
Other deductions      
Disclosure of other provisions [line items]      
Provisions for discounts, rebates and sales returns, beginning balance 60 [1] 70 [1] 34
Changes in scope of consolidation [2]     4
Provision related to current period sales 482 256 182
Net change in provision related to prior period sales 14 23 19
Payments made (496) (278) (166)
Currency translation differences (2) (15) 1
Increase Decrease Through Reclassification of Business, Other Provisions [3] (3)    
Provisions for discounts, rebates and sales returns, ending balance [1] 56 60 70
US      
Disclosure of other provisions [line items]      
Provisions for discounts, rebates and sales returns, beginning balance 5,124 4,270  
Provisions for discounts, rebates and sales returns, ending balance 4,823 5,124 4,270
US | Managed care      
Disclosure of other provisions [line items]      
Provisions for discounts, rebates and sales returns, beginning balance 1,028 934  
Provisions for discounts, rebates and sales returns, ending balance 1,097 1,028 934
Medicaid | US | Government and State Programs      
Disclosure of other provisions [line items]      
Provisions for discounts, rebates and sales returns, beginning balance 1,421 1,307  
Provisions for discounts, rebates and sales returns, ending balance 1,193 1,421 1,307
Medicare | US | Government and State Programs      
Disclosure of other provisions [line items]      
Provisions for discounts, rebates and sales returns, beginning balance 1,099 775  
Provisions for discounts, rebates and sales returns, ending balance € 722 € 1,099 € 775
[1] (c)Provisions related to US net sales amounted to €4,823 million as of December 31, 2024, €5,124 million as of December 31, 2023 and €4,270 million as
of December 31, 2022.
[2] (a)Primarily US government programs: Medicaid (€1,193 million in 2024, €1,421 million in 2023, €1,307 million in 2022) and Medicare (€722 million in 2024,
€1,099 million in 2023 and €775 million in 2022).
[3] (d)This line comprises provisions for discounts, rebates and sales returns related to Opella, reclassified as of December 31 ,2024 within Liabilities for assets held for sale in accordance with IFRS 5 (see Note D.1.)
[4] (b)Mainly rebates and other price reductions granted to healthcare authorities in the United States (including Managed Care: €1,097 million in 2024,
€1,028 million in 2023 and €934 million in 2022).